DATASHEET
Host:
Rabbit
Target Protein:
IGF1R Tyr980
Modification Site:
Tyr980
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
3480
Swiss Prot:
P08069
Source:
KLH conjugated synthetic phosphopeptide derived from human IGF1R around the phosphorylation site of Tyr980
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin.
PRODUCT SPECIFIC PUBLICATIONS
- Tang, Hexiao, et al. "Estrogen and insulin?\like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice."International Journal of Cancer (2013)..Read more>>
- Lee, Yongik, et al. "Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells." Molecular Carcinogenesis (2015).Read more>>
- Tang et al. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice. (2013) Int.J.Cancer. 133:2473-82Read more>>
- Zhiyuan Wang. et al. IGF1c mimetic peptide-based supramolecular hydrogel microspheres synergize with neural stem cells to promote functional recovery from spinal cord injury. NANO TODAY. 2023 Aug;51:101894Read more>>
VALIDATION IMAGES
Formalin-fixed and paraffin embedded human kidney carcinoma labeled with Anti phospho-IGF1R(Tyr980) Polyclonal Antibody,Unconjugated (bs-5447R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
MCF7 cells were incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with IGF1R (Tyr980) Antibody(bs-5447R)at 1:50 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2%BSA in PBS, followed by secondary antibody incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).
MCF7 cells were incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with IGF1R (Tyr980) Polyclonal Antibody(bs-5447R)at 1:50 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2%BSA in PBS, followed by secondary antibody incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).